Supernus Wins Ban On Generic Seizure Treatment
A New Jersey federal judge has handed a win to Supernus Pharmaceuticals Inc. in its bid to bar a competitor from being able to market a generic version of a seizure...To view the full article, register now.
Already a subscriber? Click here to view full article